Insider · CIK 0001754067
Timothy P Kelly
Files at CRBU (Caribou Biosciences, Inc.). First filing Feb 24, 2026, latest Feb 27, 2026.
In brief
Timothy P Kelly files SEC Form 4 as officer at CRBU (Caribou Biosciences, Inc.). Since Feb 24, 2026, Timothy P Kelly has reported 0 open-market buys worth $0 and 2 open-market sells worth $18k, the latest filed on Feb 27, 2026.
A track record needs three past buys with six months of prices behind them; Timothy P Kelly has 0, so none is measured yet.
The newest scored trade: sold $12k of CRBU on Feb 25, 2026, filed Feb 27, 2026, scored 30 (weak). In the last 12 months: 0 buys worth $0 and 2 sells worth $18k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CRBU: Caribou Biosciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Caribou Biosciences, Inc. | $12k 6,228 shares | -8% | +166% from low-31% from high | |
| 30Weak | Caribou Biosciences, Inc. | $6,168 3,147 shares | -4% | +192% from low-25% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 25, 2026 | CRBU CARIBOU BIOSCIENCES, INC. | 6,228 0.01% of outstanding | $12k | Feb 25, 2026 | $6,162 |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | CRBU Caribou Biosciences, Inc. | SOpen-market sale Common Stock | -6,228 | $1.93 | $12k | 73,125 | Feb 27, 2026 |
| Feb 20, 2026 | CRBU Caribou Biosciences, Inc. | AGrant or award Common Stock | +45,000 | $0.00 | $0 | 82,500 | Feb 24, 2026 |
| Feb 24, 2026 | CRBU Caribou Biosciences, Inc. | SOpen-market sale Common Stock | -3,147 | $1.96 | $6,168 | 79,353 | Feb 24, 2026 |
| Feb 20, 2026 | CRBU Caribou Biosciences, Inc. | AGrant or award Option to purchase Common Stockderivative | +202,500 | $0.00 | $0 | 202,500 | Feb 24, 2026 |
| Feb 20, 2025 | CRBU Caribou Biosciences, Inc. | AGrant or award Common Stock | +37,500 | $0.00 | $0 | 37,500 | Feb 21, 2025 |
| Feb 20, 2025 | CRBU Caribou Biosciences, Inc. | AGrant or award Option to purchase Common Stockderivative | +170,000 | $0.00 | $0 | 170,000 | Feb 21, 2025 |
Questions about Timothy P Kelly
Answered from the filings on this page, as of the latest one.
Is Timothy P Kelly buying or selling?
In the last 12 months Timothy P Kelly reported 0 open-market buys worth $0 and 2 open-market sells worth $18k on SEC Form 4; the latest was sold $12k of CRBU on Feb 25, 2026. Grants, option exercises and tax withholding are not counted.
How did Timothy P Kelly's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Timothy P Kelly has 0.
Where does Timothy P Kelly file Form 4?
Timothy P Kelly has filed Form 4 at CRBU (Caribou Biosciences, Inc.) as Chief Technology Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.